Literature DB >> 2709285

Primary disorders of the lymphatic vessels--a unified concept.

C Levine1.   

Abstract

Congenital defects of lymphatics constitute a spectrum of disorders that may manifest with a variety of clinical presentations including lymphedema, chylous effusions, lymphangiomatous malformations with cystic masses and localized gigantism, and intestinal lymphangiectasia with malabsorption. These entities constitute a relatively rare group of disorders, the origin of which remains somewhat controversial, but in some it appears to be due to early lymphatic obstruction. Five cases are described, which demonstrate the anatomical pathology of these entities. A classification and description of the defects is also presented. An attempt is made to present a unified theory of origin for this seemingly diverse group of diseases. While these entities may be challenging from a diagnostic and therapeutic standpoint, a wide variety of imaging modalities, which includes lymphography, computed tomography scanning, and ultrasound, may be used to diagnose the extent and internal structural characteristics of the abnormalities.

Entities:  

Mesh:

Year:  1989        PMID: 2709285     DOI: 10.1016/s0022-3468(89)80001-6

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  18 in total

1.  Generalised lymphangiectasia: pulmonary presentation in an adult.

Authors:  J E White; D Veale; D Fishwick; L Mitchell; P A Corris
Journal:  Thorax       Date:  1996-07       Impact factor: 9.139

2.  Thoracic lymphangiomatosis with massive chylothorax after a tumor biopsy and with disseminated intravenous coagulation--lymphoscintigraphy, an alternative minimally invasive imaging technique: report of a case.

Authors:  Suguru Fukahori; Tomomitsu Tsuru; Kimio Asagiri; Hirotaka Nakamizo; Takahiro Asakawa; Hiroaki Tanaka; Yoshiaki Tanaka; Jun Akiba; Hirohisa Yano; Minoru Yagi
Journal:  Surg Today       Date:  2011-07-12       Impact factor: 2.549

3.  Sudden death of a 14-year-old girl with lymphangiomatosis.

Authors:  Tomoki Nakagawa; Takahisa Koizumi; Kana Oiwa; Chie Inomoto; Go Ogura; Ryota Masuda; Tomohiro Yamashita; Naoya Nakamura; Masayuki Iwazaki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-07-23

4.  Intra Abdominal Cystic Lymphangioma in an Adult.

Authors:  A Y Kshirsagar; J V Wader; F Suleman; S Pujari
Journal:  Med J Armed Forces India       Date:  2011-07-21

5.  Congenital chylothorax treated with octreotide.

Authors:  Yasin Sahin; Derya Aydin
Journal:  Indian J Pediatr       Date:  2005-10       Impact factor: 1.967

6.  Neurotrophic keratitis in a patient with disseminated lymphangiomatosis.

Authors:  Jared E Knickelbein; Susan T Stefko; Puwat Charukamnoetkanok
Journal:  Eye Brain       Date:  2009-10-20

7.  Renal lymphangiomatosis, interrupted IVC with persistent primitive hepatic venous plexus and multiple anomalous venous channels: parts of an overlap syndrome?

Authors:  Tom Watson; Ester Martinez; David Crabbe; Phillip Chetcuti; Jeannette K Kraft
Journal:  Pediatr Radiol       Date:  2011-07-20

8.  ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor.

Authors:  Dong Li; Michael E March; Alvaro Gutierrez-Uzquiza; Charlly Kao; Christoph Seiler; Erin Pinto; Leticia S Matsuoka; Mark R Battig; Elizabeth J Bhoj; Tara L Wenger; Lifeng Tian; Nora Robinson; Tiancheng Wang; Yichuan Liu; Brant M Weinstein; Matthew Swift; Hyun Min Jung; Courtney N Kaminski; Rosetta Chiavacci; Jonathan A Perkins; Michael A Levine; Patrick M A Sleiman; Patricia J Hicks; Janet T Strausbaugh; Jean B Belasco; Yoav Dori; Hakon Hakonarson
Journal:  Nat Med       Date:  2019-07-01       Impact factor: 53.440

9.  The swollen leg and primary lymphoedema.

Authors:  N B Wright; H M Carty
Journal:  Arch Dis Child       Date:  1994-07       Impact factor: 3.791

10.  Intestinal lymphangiectasia - a report of two cases.

Authors:  M V Rashmi; B Niranjana Murthy; Hephzibah Rani; C R Kodandaswamy; Srinivas Arava
Journal:  Indian J Surg       Date:  2010-07-01       Impact factor: 0.656

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.